Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Technology Transfer

26 Jun 2013 - 28 Jun 2013 - London, UK

Bookmark and Share

This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology and to highlight some proven techniques for overcoming those challenges.

The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.

Some of the benefits to be derived from this workshop include:

  • An appreciation of where TT fits in the life cycle of a pharmaceutical product.
  • An appreciation of the importance of planning and project management in TT
  • An overview of the potential complexity of technology and product transfer.
  • An outline of proven best practice in technology transfer.
  • An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
  • A consideration of 'where next' as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.

Who Should Attend?

Pharmaceutical technologists, Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and anybody else involved in the transfer of products or technology from one location to another.

Course Programme

Day 1

Why Transfer Technology?

Pharmaceutical Product Life Cycle

  • Development
  • Innovative
  • Mature
  • Generic

Product Transfers and Technology Transfers

  • IP
  • Technology
  • Techniques
  • Regulatory Considerations

Registration Procedures

  • Europe
  • Non-European

Variation Procedures

  • Types of Variations
  • Advantages and Disadvantages

Day 2

Technical Challenges

  • Manufacturing processes
  • Validation
  • Stability
  • Packaging processes

Logistical Challenges

  • Label Changes * Text * Physical
  • Timing * Project Plan * Phase in/out

Day 3

Technical Challenges (2)

Impact of new technology

  •  Quality by Design
  •  Process Analytical Technology

Human Challenges

  • Push versus Pull
  • Team membership and team roles
  • Cross-Cultural Issues
  • Progress Reporting and breaking bad news

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos